Literature DB >> 8912909

Human olfactory neuroepithelial cells: tyrosine phosphorylation and process extension are increased by the combination of IL-1beta, IL-6, NGF, and bFGF.

M P Vawter1, J Basaric-Keys, Y Li, D S Lester, R S Lebovics, K P Lesch, H Kulaga, W J Freed, T Sunderland, B Wolozin.   

Abstract

Olfactory neuroepithelial cells (ONC) grown from biopsies of human donors are a novel cell culture system that may facilitate studies into normal and disease-related human neurobiology. We further characterized the expression of cell surface markers and intermediate filaments, and responses to neurotrophic factors by ONC. ONC are positive for cell surface markers N-CAM, PSA-N-CAM, neutral endopeptidase, N-aminopeptidase, NGF low-affinity receptor homologue (CD40), and transferrin receptor by flow cytometry for the intermediate filament proteins peripherin, vimentin, and NF-H by immunocytochemistry. Responses to neurotrophic factors measured were process outgrowth, cytoskeletal protein expression, and protein phosphorylation. Process outgrowth was increased by interleukin-beta 164-171 (IL-1beta) or by the combination of IL-1beta, interleukin-6 (IL-6), nerve growth factor (NGF), and basic fibroblast growth factor (bFGF). This combination of IL-1beta, IL-6, NGF, and bFGF (16NF) increased expression of two cytoskeletal proteins, NF-H protein and microtubule-associated protein tau. Application of the individual neurotrophic factors IL-1beta, IL-6, NGF, and bFGF increased protein phosphorylation, while 16NF produced an immediate increase in tyrosine phosphorylation of several proteins (MW of 40-80, 120, 150, and 190 kDa). The 16NF combination appears to act through a tyrosine-kinase-mediated pathway to induce process extension and increase NF-H expression. The ONC culture has the potential to be further explored to examine the relationship among process outgrowth, protein phosphorylation, and synergy between neurotrophin and cytokine receptor systems.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912909     DOI: 10.1006/exnr.1996.0189

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo.

Authors:  J G Sheng; S G Zhu; R A Jones; W S Griffin; R E Mrak
Journal:  Exp Neurol       Date:  2000-06       Impact factor: 5.330

2.  Analysis of whole genome biomarker expression in blood and brain.

Authors:  Brandi Rollins; Maureen V Martin; Ling Morgan; Marquis P Vawter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-06-05       Impact factor: 3.568

Review 3.  Therapeutic potential of olfactory ensheathing cells in neurodegenerative diseases.

Authors:  Shao-Chih Chiu; Huey-Shan Hung; Shinn-Zong Lin; Esheral Chiang; Demeral David Liu
Journal:  J Mol Med (Berl)       Date:  2009-09-10       Impact factor: 4.599

Review 4.  Neural stem cell niches in health and diseases.

Authors:  Ilaria Decimo; Francesco Bifari; Mauro Krampera; Guido Fumagalli
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 5.  Translational potential of olfactory mucosa for the study of neuropsychiatric illness.

Authors:  K Borgmann-Winter; S L Willard; D Sinclair; N Mirza; B Turetsky; S Berretta; C-G Hahn
Journal:  Transl Psychiatry       Date:  2015-03-17       Impact factor: 6.222

6.  Hendra and Nipah Virus Infection in Cultured Human Olfactory Epithelial Cells.

Authors:  Viktoriya Borisevich; Mehmet Hakan Ozdener; Bilal Malik; Barry Rockx
Journal:  mSphere       Date:  2017-06-28       Impact factor: 4.389

7.  Diclofenac reduces the risk of Alzheimer's disease: a pilot analysis of NSAIDs in two US veteran populations.

Authors:  Olaf Stuve; Rick A Weideman; Danni M McMahan; David A Jacob; Bertis B Little
Journal:  Ther Adv Neurol Disord       Date:  2020-06-25       Impact factor: 6.570

Review 8.  Coronaviruses and the central nervous system.

Authors:  Susan Morgello
Journal:  J Neurovirol       Date:  2020-07-31       Impact factor: 3.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.